These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 336545)

  • 21. Lipids of antibiotic-resistant and -susceptible members of the Enterobacteriaceae.
    Suling WJ; O'Leary WM
    Can J Microbiol; 1977 Aug; 23(8):1045-51. PubMed ID: 329961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation of transmural complement pores in serum-sensitive Escherichia coli.
    Bhakdi S; Kuller G; Muhly M; Fromm S; Seibert G; Parrisius J
    Infect Immun; 1987 Jan; 55(1):206-10. PubMed ID: 3539803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major outer membrane proteins of Escherichia coli strains of human origin.
    Overbeeke N; Lugtenberg B
    J Gen Microbiol; 1980 Dec; 121(2):373-80. PubMed ID: 7021763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic manipulation of membrane phospholipid composition in Escherichia coli: pgsA mutants defective in phosphatidylglycerol synthesis.
    Miyazaki C; Kuroda M; Ohta A; Shibuya I
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7530-4. PubMed ID: 2999767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiolipin accumulation in the inner and outer membranes of Escherichia coli mutants defective in phosphatidylserine synthetase.
    Raetz CR; Kantor GD; Nishijima M; Newman KF
    J Bacteriol; 1979 Aug; 139(2):544-51. PubMed ID: 222736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of turkey complement with Escherichia coli isolated from turkeys.
    Ellis MG; Arp LH; Lamont SJ
    Am J Vet Res; 1989 Aug; 50(8):1285-9. PubMed ID: 2675694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-lipid interactions in biological and model membrane systems. Deuterium NMR of Acholeplasma laidlawii B, Escherichia coli, and cytochrome oxidase systems containing specifically deuterated lipids.
    Kang SY; Kinsey RA; Rajan S; Gutowsky HS; Gabridge MG; Oldfield E
    J Biol Chem; 1981 Feb; 256(3):1155-9. PubMed ID: 6256386
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of a cationic surfactant-resistant mutant isolated spontaneously from Escherichia coli.
    Ishikawa S; Matsumura Y; Yoshizako F; Tsuchido T
    J Appl Microbiol; 2002; 92(2):261-8. PubMed ID: 11849354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation.
    Wooster DG; Maruvada R; Blom AM; Prasadarao NV
    Immunology; 2006 Apr; 117(4):482-93. PubMed ID: 16556262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance of Escherichia coli to osmotically introduced complement component C9.
    Dankert JR
    Infect Immun; 1991 Jan; 59(1):109-13. PubMed ID: 1987022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty acids and phospholipids of membranes isolated from Escherichia coli growing in a medium with parathion.
    Rosas SB; Carranza de Storani MM; Ghittoni NE
    Bull Environ Contam Toxicol; 1985 Feb; 34(2):265-70. PubMed ID: 3884065
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on serum resistance in Escherichia coli.
    Kubens BS; Opferkuch W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):52-65. PubMed ID: 3146846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Lectin Complement Pathway Is Involved in Protection Against Enteroaggregative
    Adler Sørensen C; Rosbjerg A; Hebbelstrup Jensen B; Krogfelt KA; Garred P
    Front Immunol; 2018; 9():1153. PubMed ID: 29896194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C5b-7 and C5b-8 precursors of the membrane attack complex (C5b-9) are effective killers of E. coli J5 during serum incubation.
    Bloch EF; Knight EM; Carmon T; McDonald-Pinkett S; Carter J; Boomer A; Ogunfusika M; Petersen M; Famakin B; Aniagolu J; Walker J; Gant R; Walters CS; Gaither TA
    Immunol Invest; 1997 Jun; 26(4):409-19. PubMed ID: 9246562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.
    Madsen LM; Inada M; Weiss J
    Infect Immun; 1996 Jul; 64(7):2425-30. PubMed ID: 8698462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial killing by complement. C9-mediated killing in the absence of C5b-8.
    Dankert JR; Esser AF
    Biochem J; 1987 Jun; 244(2):393-9. PubMed ID: 3311029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cytolytic C5b-9 complement complex: feedback inhibition of complement activation.
    Bhakdi S; Maillet F; Muhly M; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1912-6. PubMed ID: 3162317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid method for isolation of large quantities of outer membrane from Escherichia coli K-12 and its application to the study of envelope mutants.
    Wolf-Watz H; Normark S; Bloom GD
    J Bacteriol; 1973 Sep; 115(3):1191-7. PubMed ID: 4199509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does complement kill E. coli by producing transmural pores?
    Born J; Bhakdi S
    Immunology; 1986 Sep; 59(1):139-45. PubMed ID: 3530981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.